The current financial score of Xtant Medical Holdings Inc is 6.67. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 23.03M, representing a year-over-year decrease of 34.96%, while its net profit experienced a year-over-year decrease of 365.15%.
The current valuation score of Xtant Medical Holdings Inc is 8.13. Its current P/E ratio is 24.85, which is 829.84% below the recent high of 231.05 and 552.04% above the recent low of -112.32.
The current earnings forecast score of Xtant Medical Holdings Inc is 8.00. The average price target is 1.03, with a high of 1.50 and a low of 0.60.
The current price momentum score of Xtant Medical Holdings Inc is 5.67. Currently, the stock price is trading between the resistance level at 0.44 and the support level at 0.26, making it suitable for range-bound swing trading.
The current institutional shareholding score of Xtant Medical Holdings Inc is 10.00. The latest institutional shareholding proportion is 114.61%, representing a quarter-over-quarter increase of 92.41%. The largest institutional shareholder is James Simons, holding a total of 935.12K shares, representing 0.00% of shares outstanding, with 7.11% increase in holdings.
The current risk assessment score of Xtant Medical Holdings Inc is 2.23. The company's beta value is -0.15. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.